© 2021 MJH Life Sciences and AJMC. All rights reserved.
© 2021 MJH Life Sciences™ and Clinical Care Targeted Communications, LLC. All rights reserved.
March 08, 2016
Results of the study in JAMA underscore the importance of advance care planning.
March 07, 2016
Panelists discussing quality metrics in oncology were not sure payment and federal policies could keep pace with what's happening on the front lines.
CMS has attempted to tailor ACOs to meet a variety of needs and levels of risk, depending on where parties are in their knowledge level of payment reform.
Yousuf Zafar, MD, MHS, found that most cancer patients would like to discuss financial concerns with their doctors, but few actually do, for a variety of reasons.
March 06, 2016
Flatiron Health seeks to use data to prevent the patient experience from being lost.
March 05, 2016
The pharmacy benefit manager may be the "new sheriff in town" in an era of rising costs.
March 04, 2016
Choosing a therapy with fewer side effects can increase efficacy because patients stick with it, said Stacey McCullough, PharmD, of Tennessee Oncology.
Immunotherapy represents the "next frontier" in cancer care, according to Joseph Alvarnas, MD, of City of Hope, who is editor-in-chief of Evidence-Based Oncology.
After being diagnosed with a rare blood cancer, Jack Whelan has used his electronic connections to be more involved in his care.
March 03, 2016
Broad treatment guidelines may be based on relatively narrow trial data.
Oncologists now face a cost discussion that was not part of their medical training. It's a balancing act between the big picture of understanding the burdens on the system and "the patient in front of you."
Keynote speaker Dr Julie Vose said the oncologist faces many administrative burdens in the transition to value-based care. Solving them is essential to spending more time with the patient.
March 02, 2016
The timely panel took place just after FDA issued a report on why it feels regulatory oversight of testing is necessary.
A thorough family history is the foundation of precision medicine, according to the 2015 president of the National Society of Genetic Counselors.
Emanuel F. Petricoin III, PhD, said patients have much to gain from "democratization" as clinical trials move beyond academic centers.